Toshikazu Nakamura
Records under this name other than patents Toshikazu Nakamura holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Toshikazu Nakamura
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,058,590 | Methods of treating amyotrophic lateral sclerosis by HGF Term ended Term ended Feb 28, 2021 · USPTO record | Term ended | Term ended Feb 28, 2021 | USPTO record |
| US 6,436,388 | Method of treating rhabdomyolysis by administering hepatocyte growth factor Term ended Term ended Feb 24, 2020 · USPTO record | Term ended | Term ended Feb 24, 2020 | USPTO record |
| US 6,036,972 | Method of treating dilated cardiomyopathy Term ended Term ended Oct 14, 2017 · USPTO record | Term ended | Term ended Oct 14, 2017 | USPTO record |
| US 6,869,609 | Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor Lapsed on the fee record Ended Mar 22, 2017 · USPTO record | Lapsed on the fee record | Ended Mar 22, 2017 | USPTO record |
| US 6,756,358 | Therapeutic agent for cartilaginous diseases Term ended Term ended Jan 30, 2015 · USPTO record | Term ended | Term ended Jan 30, 2015 | USPTO record |
| US 5,342,831 | Epitheliocyte growth accelerator Term ended Term ended no later than Aug 30, 2014 · Low confidence | Term ended | Term ended no later than Aug 30, 2014 | Low confidence |
| US 5,840,311 | Agent accelerating collagen decomposition Formerly held Term ended Term ended no later than Nov 24, 2018 · Low confidence | Term ended | Term ended no later than Nov 24, 2018 | Low confidence |
| US 5,977,310 | Peg-modified HGF Formerly held Term ended Term ended no later than Nov 2, 2019 · Low confidence | Term ended | Term ended no later than Nov 2, 2019 | Low confidence |